Healthcare
NATCO Pharma Limited (NATCOPHARM)
NATCO Pharma Limited (NATCOPHARM) is an NSE-listed Healthcare company. latest close ₹882.4, 1-day return +0.6%, 1-week return -2.3%. This page shows price, returns, and technical signals from QUANTSCASE. Informational only — not investment advice.
Data as of 20 Aug 2026
For informational and educational purposes only. Not investment advice. QUANTSCASE is a stock screener, not a SEBI-registered investment adviser, research analyst, or portfolio manager. Terms
Price & returns
- Last close
- ₹882.4
- 1-day return
- +0.6%
- 1-week return
- -2.3%
- 1-month return
- -5.5%
Technical signals
Latest daily indicators. These are screen readings, not buy or sell calls.
- RSI (14)
- 38.3
- ADX (14)
- 13.5
- ROC 10
- -3.7%
- vs 52W high
- -28.1%
Fundamentals snapshot
Latest fields from our NSE fundamentals table. Figures can lag the live tape.
- Market cap
- ₹15,805 Cr
- P/E
- 13.8
- P/B
- 1.71
- ROE
- —
- D/E
- 7.74
- Net margin
- 32.8%
- Rev. growth YoY
- -39.5%
- Div. yield
- 74.0%
- 52W high
- ₹1,226.8
- 52W low
- ₹789
- EPS (TTM)
- ₹63.89
Live signals
Built from the latest price, 1-day / 1-week return, and technical snapshot — not a news calendar.
- signal
1-day return +0.6%
Latest 1-day price change versus the previous close.
- signal
1-week return -2.3%
Price change over the last five trading sessions.
News & screener mentions
Recent QUANTSCASE daily posts that listed NATCOPHARM.
No recent screener posts mentioned NATCOPHARM yet. New daily posts will show up here automatically.
